NF2 and central nervous system cancer: Furthermore, PDGF in combination with AdCre;Nf2 gave a higher TTR of 52% (33–71%) with 66% being grade 1, 40% grade 2, and 20% grade 3; however, there was still a high number of gliomas (48%) and a shorter median survival of 189 days.